HomeLearn › Stopping GLP-1

The Maintenance Phase

What happens when you stop GLP-1 injections?

Injectable GLP-1 medications quiet appetite signals while you take them. When the medication stops, those signals come back — and that's exactly when most plans fall apart. Here's what to expect, and why the phase after injections deserves as much attention as the weight-loss phase itself.

Woman using a needle-free sublingual maintenance spray

Appetite signaling returns first

GLP-1 receptor agonists work in part by supporting satiety — the feeling of fullness that tells you to stop eating. As the medication leaves your system over the weeks after your last dose, many people notice hunger returning to pre-treatment levels, and sometimes cravings — especially for sugar and refined carbohydrates — resurface before anything shows on the scale.

What the research suggests about weight regain

Published research on GLP-1 discontinuation has reported that many patients regain a significant share of lost weight within a year of stopping — figures around 60–70% of lost weight regained within 12 months are commonly cited. Researchers increasingly describe obesity as a chronic, relapsing condition: when treatment stops without a maintenance plan, the underlying biology tends to reassert itself. Individual results vary widely.

Why "willpower" isn't a maintenance plan

The return of appetite after stopping a GLP-1 isn't a character flaw — it's physiology. Hormonal signals that drive hunger were suppressed by medication, not retrained. That's why clinicians often talk about a maintenance phase: a deliberate plan for the months after weight loss, which may include nutrition and activity strategies, ongoing provider check-ins, and — for some eligible patients — continued medication support in a different form.

Building a maintenance plan

Wondering where you stand? Our 60-second eligibility check is a free, no-pressure way to see whether a provider conversation makes sense for you.

Important safety information

  • • This article is educational only and is not medical advice. Always consult a licensed healthcare provider about starting, stopping, or changing any medication.
  • • THIN™, THIN-R™, and THIN-ST™ are prescription-only compounded medications, prepared by licensed 503A pharmacies. They are not FDA-approved, and are dispensed only if a licensed provider determines they are medically appropriate.
  • • Payment does not guarantee a prescription. Individual results vary.
Built for the Next Phase

Have a plan before the last injection.

A licensed provider can help you decide what the maintenance phase should look like for you.

Start Your Telehealth Visit